Calgene Footer

Unveiling Advances in GU Cancers: Insights from Oncology Decoded

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;John Burke, MD;Dhaval R. Shah, MBBS

Bemarituzumab Regimen Improves Survival in FGFR2b+ Gastric/GEJ Cancer

Dive into the latest in genitourinary oncology with "Oncology Decoded," featuring discussions on KEYNOTE-564 with RCC.

Investigators will present detailed results from the phase 3 FORTITUDE-101 trial at a future medical meeting.

Harnessing PIPAC to Improve Outcomes in Peritoneal Carcinomatosis

Investigators will present detailed results from the phase 3 FORTITUDE-101 trial at a future medical meeting.

Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.

Benjamin J. Golas, MD

June 30th 2025

Video-Based Genetic Counseling Improves Comprehension in HBOC

Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.

In those being screened for hereditary breast and ovarian cancer syndrome, use of a video tool improved the duration of physician-led genetic counseling.

Tim Cortese

Sunvozertinib Earns FDA Accelerated Approval in EGFR Exon 20+ NSCLC

In those being screened for hereditary breast and ovarian cancer syndrome, use of a video tool improved the duration of physician-led genetic counseling.

Data from the phase 1/2 WU-KONG1 study support the accelerated approval of sunvozertinib in this population.

July 2nd 2025

15 Utilizing Circulating Tumor Cells to Guide HER2-Directed Therapy in IHC/FISH-Negative HER2+ Metastatic Breast Cancer

Data from the phase 1/2 WU-KONG1 study support the accelerated approval of sunvozertinib in this population.

Related Content

Diana Jaber;Natalie K Heater;Surbhi Warrior;Janice Lu, MD, PhD

Unveiling Advances in GU Cancers: Insights from Oncology Decoded

Manojkumar Bupathi, MD, MS;Benjamin Garmezy, MD;John Burke, MD;Dhaval R. Shah, MBBS

Bemarituzumab Regimen Improves Survival in FGFR2b+ Gastric/GEJ Cancer

Dive into the latest in genitourinary oncology with "Oncology Decoded," featuring discussions on KEYNOTE-564 with RCC.

Harnessing PIPAC to Improve Outcomes in Peritoneal Carcinomatosis

Investigators will present detailed results from the phase 3 FORTITUDE-101 trial at a future medical meeting.

Benjamin J. Golas, MD

June 30th 2025

Video-Based Genetic Counseling Improves Comprehension in HBOC

Benjamin Golas, MD, discusses how the use of PIPAC may work in conjunction with systemic chemotherapy for those with peritoneal carcinomatosis.

Tim Cortese

Sunvozertinib Earns FDA Accelerated Approval in EGFR Exon 20+ NSCLC

In those being screened for hereditary breast and ovarian cancer syndrome, use of a video tool improved the duration of physician-led genetic counseling.

July 2nd 2025